Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Jennifer Li

Vascular Surgery Boston, MA Medical Doctor

NPI 1447609235 CMS profile 2049277

110 Francis St, Suite 9B, Boston, MA 02215

Open in the dashboard

General payments

$9,713

84 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Jennifer Li of Boston, MA is reported in the CMS Open Payments database as having received $9,713 across 84 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 67th percentile of Vascular Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $2,606 25
2024 General $2,727 29
2023 General $2,440 13
2022 General $1,282 14
2021 General $158 1
2020 General $375 1
2019 General $124 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Jennifer Li
  • Vascular Surgery median
  • Middle half of Vascular Surgery
  • National median

In program year 2025, general payments to Jennifer Li were reported at $2,606. Among 3,991 Vascular Surgery profiles paid that year, the median was $924 and the middle half received between $273 and $2,636.

Show as a table
Year Jennifer Li Vascular Surgery median Middle half National median
2019 $124 $796 $226–$2,363 $163
2020 $375 $348 $118–$1,110 $114
2021 $158 $471 $158–$1,421 $132
2022 $1,282 $725 $222–$2,183 $149
2023 $2,440 $836 $257–$2,440 $160
2024 $2,727 $909 $252–$2,619 $164
2025 $2,606 $924 $273–$2,636 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Boston Scientific Corporation $1,768 15 payments
  2. W. L. Gore & Associates, Inc. $1,558 24 payments
  3. Bolton Medical Inc $1,183 12 payments
  4. Cook Incorporated $1,150 1 payment
  5. Silk Road Medical, Inc. $1,018 7 payments
  6. Medtronic Vascular, Inc. $499 2 payments
  7. Medtronic, Inc. $321 2 payments
  8. Kerecis Limited $319 2 payments
  9. Shape Memory Medical Inc. $306 1 payment
  10. Inari Medical, Inc. $292 1 payment
  11. Other $1,299 17 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $7,905 80 payments
  2. Grant $1,150 1 payment
  3. Education $657 3 payments
Products named General payments · program years 2019–2025
  1. TREO ABDOMINAL STENT-GRAFT SYSTEM $1,183 12 payments
  2. ENROUTE Transcarotid Neuroprotection System $1,018 7 payments
  3. ENROUTE Transcarotid Stent $1,018 7 payments
  4. EXCLUDER Conformable AAA Endoprosthesis with Active Control $573 11 payments
  5. GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis $350 2 payments
  6. General - Angioplasty $350 3 payments
  7. Kerecis Omega3 SurgiClose $319 2 payments
  8. IMPEDE EMBOLIZATION PLUG $306 1 payment
  9. FLOWTRIEVER CATHETER, S $292 1 payment
  10. CT THROMBECTOMY SYSTEM KIT $292 1 payment
  11. Other $4,776 50 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 93 billing codes

Paid by Medicare

$92,636

Medicare's payments for the services billed

Medicare patients

835

Average age 75

Services billed

1,458

384 women, 451 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 61%
Diabetes 59%
Heart failure 55%
Arthritis 53%
Chronic kidney disease 51%
Atrial fibrillation 43%
Depression 36%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

1 product · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
XARELTO
  • Janssen Pharmaceuticals, Inc $19
$19 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

84 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Vascular Surgery in Massachusetts

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record